Track the 인트론바이오 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 인트론바이오 has published 37 reports. Market capitalisation: €88.4bn. The latest transaction was reported on 3 July 2026 (Purchase). Among the most active insiders: 윤성준. Every trade is free.
37
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
6 ops.
Sell Volume
Fundamental score
Ranked 23,243 of 29,156 companies
30.9
score / 100
Value
17
Quality
45
FCF yld-8.7%
Earn yld-10%
EV/EBITDA·
ROE-12%
Gross mgn54%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
인트론바이오 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.